You are here: Industry Insights > Market News > India, China may start producing Sputnik V vaccine: Putin

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Hot Sale Safe Folic Acid--Naturalized Folate Raw Material

Halal Atropa Belladonna Extract Powder10:1

Halal Atractylodis Macrocephalae Rhizoma Extract Powder 10:1

Halal Atractylodes Macrocephala Extract Powder 10:1

Halal Atractylodes Lancea Extract Powder10:1

Halal Astragalus Root Extract Powder10:1

India, China may start producing Sputnik V vaccine: Putin

expresspharmaNovember 18, 2020

Tag: COVID-19 , Sputnik V vaccine , china , India

Favorites

India and China may start producing Russia’s Sputnik V vaccine against COVID-19, the RIA news agency cited President Vladimir Putin as saying.

Putin also proposed that the creation of a vaccine research centre for BRICS countries – Brazil, Russia, India, China and South Africa – be sped up, TASS reported.

Recently, RDIF and Gamaleya Institute had issued a statement claiming that as per interim trial results, the Sputnik-V vaccine is 92 per cent effective at preventing COVID-19.

Previous:Foxx Life Sciences to open Asia headquarters in Medchal, Hyderabad

Next:T2D market will grow from a total of $48.1bn sales in 2019 to $91.9 bn in 2029

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

India, China may start producing Sputnik V vaccine: Putin | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

China Disinfectants

Echinacea Extract Powder

Organic Purity Natural 4% Polyphenols 1% Cichoric Acid Echinacea Purpurea Extract Echinacea Extract

China Supplier Wholesale Kosher Halal Certificate Herbal Alpha- Mangostin Tea Seeds M1 M2 M1Ps M8 Fr

Cooling bath made in china -25 up to 200 degree

L-Citrulline AJI92/97 Amino acid made in china

Fluticasone propionate ≥97.0% Hormone API made in china

Fluvoxamine maleate USP Pharmaceutical API Depression made in china

Ichthammol CP 98%min supplier Pharmaceutical API Antiseptics made in china

China Reliable Factory Supply New Zealand Bulk Pure Freeze Dried Extract Green Lipped Mussel Powder

India, China may start producing Sputnik V vaccine: Putin

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>